Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial

Tashkin D. P., Celli B., Kesten S., Lystig T., Mehra S., Decramer M.

Source: Eur Respir J 2010; 35: 287-294
Journal Issue: February
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Tashkin D. P., Celli B., Kesten S., Lystig T., Mehra S., Decramer M.. Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial. Eur Respir J 2010; 35: 287-294

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictors of long-term smoking cessation in patients with COPD: results from a randomised controlled trial
Source: Eur Respir J, 49 (6) 1700561; 10.1183/13993003.00561-2017
Year: 2017



Effectiveness of combination therapy with tiotropium in COPD. A secondary analysis of the UPLIFT trial
Source: Annual Congress 2009 - Functional insights into COPD
Year: 2009

Tiotropium reduces the risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008

Clinical effectiveness of MDI-HFA-Modulite budesonide in the treatment of asthma – meta-analysis of randomised controlled trials
Source: Eur Respir J 2006; 28: Suppl. 50, 315s
Year: 2006

Long-term safety of twice-daily aclidinium bromide in COPD patients: A one-year, double-blind study
Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Year: 2012

Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD
Source: Annual Congress 2010 - Smoking related disorders and smoking cessation
Year: 2010

Long-term safety and efficacy of budesonide/formoterol in Japanese patients with asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008

Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial
Source: ERJ Open Res, 7 (3) 00255-2021; 10.1183/23120541.00255-2021
Year: 2021



Clinical effectiveness of MDI-HFA-Modulite beclomethasone in the treatment of asthma – meta-analysis of randomized controlled trials
Source: Eur Respir J 2006; 28: Suppl. 50, 315s
Year: 2006

Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT?
Source: ERJ Open Res 2016: 00055-2016
Year: 2016



Short-term low-dose vs standard-dose Varenicline therapy for smoking cessation: a randomized controlled trial.
Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes
Year: 2017


A multi-centre doubleblind randomised study examining the clinical outcome of treatment of the first asthma exacerbation with salmeterol xinafoate/fluticasone propionate combination product versus prednisolone
Source: Eur Respir J 2003; 22: Suppl. 45, 287s
Year: 2003

Long-term efficacy of twice-daily aclidinium bromide in COPD patients: A one-year study
Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights
Year: 2012

Randomized clinical trials with nicotine inhaler for smoking cessation
Source: Eur Respir J 2003; 22: Suppl. 45, 166s
Year: 2003

The long-term effect of an exercise and diet intervention in asthma patients: a 1-year follow-up on a randomised controlled trial
Source: ERJ Open Res, 5 (2) 00032-2019; 10.1183/23120541.00032-2019
Year: 2019



Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial
Source: Breathe, 17 (1) 200279; 10.1183/20734735.0279-2020
Year: 2021



Indacaterol once-daily improves health-related quality of life in COPD patients: a 26-week comparison with placebo and tiotropium
Source: Annual Congress 2009 - New bronchodilators
Year: 2009

Comparison of efficacy of varenicline and nortriptyline– Short-term smoking cessation in outpatient setting
Source: International Congress 2016 – Emerging issues in smoking cessation and tobacco products
Year: 2016


Cardioselective beta-blockers are not only safe in patients with COPD, but may also improve the responsibility of FEV1 to beta-agonist: A meta-analysis of randomized controlled double-blinded trials
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012

Long-term efficacy of a home-based airway clearance programme to improve cough severity in patients with bronchiectasis:a randomised controlled trial>
Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections
Year: 2019